Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Insys Therapeutics Inc. INSYQ

Healthcare Biotechnology
Insys Therapeutics Inc is a specialty pharmaceutical company. It develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve patients' quality of life. The company have two marketed products; SUBSYS, a proprietary sublingual fentanyl spray; and SYNDROS, a proprietary orally administered liquid formulation of dronabinol. The company derives revenue from selling SUBSYS and SYNDROS in various dosing packages to wholesale pharmaceutical distribu


OTCPK:INSYQ - Post by User

Insys Therapeutics Inc. > Check out TBP
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(33)
•••
Comment by TripleEmon Sep 18, 2017 11:09pm
144 Views
Post# 26712117

RE:Check out TBP

RE:Check out TBPhttps://tetrabiopharma.com/investors/press-releases/press-release-details/2017/Tetra-Bio-Pharma-getting-ready-to-file-a-clinical-trial-application-to-initiate-phase-3-clinical-trial-on-terminal-cancer-patients-in-the-coming-weeks-9182017/default.aspx
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities